Not So Fast With Cannabis-COVID Treatment: Researchers Clarify
Through
Following the promising study on cannabinoids and COVID-19 published by Oregon State University, Gb Sciences, Inc., a plant-based biopharmaceutical research and development company, pointed out that the truth behind how cannabinoids and terpenes work in therapeutic mixtures is more complicated than has been reported in the popular press.
The Gb Sciences study with Michigan State University (MSU) has produced preclinical data showing that certain compounds and ratios of these cannabis compounds are likely required for cannabinoids to be used to treat COVID-19 symptoms.
Photo by Yarygin/Getty Images
Gb Science recently reported additional study data supporting the potential of cannabinoids as a treatment option for hyperinflammation resulting from COVID-19. Gb Sciences and an MSU researcher evaluated the potential of cannabis-derived compounds to suppress immunological responses that contribute to COVID-19 symptoms. Their study and conversations received national media coverage based on an interview with the MSU researcher who dropped out of WLNS-TV in Lansing, Michigan and interviews with Gb Sciences in Cannabis Business Times and Hemp Grower magazines.
RELATED: High-purity CBD may help block replication of COVID-19, new study suggests
In the WLNS-TV interview, Norbert Kaminski, Ph.D., researcher and professor of pharmacology and toxicology at MSU, reported that his partnership with Gb Sciences has explored the potential for reducing certain compounds, cannabinoids, and terpenes from the cannabis plant in humans Inflammatory responses to COVID-19, but that this specific drug still needs time to be studied to validate both the types of compounds and their specific ratios in mixtures that will successfully combat the hyperinflammation induced by COVID-19.
“By adding these different mixes and different combinations, we can assess whether these compounds are effective in potentially helping people resolve respiratory issues associated with the virus,” Kaminski said.
Photo by Jeff W via Unsplash
RELATED: OSU Study Shows CBGA and CBDA Block COVID-19 Virus
The study is still in its early stages, but in WLNS coverage, Kaminski said both teams are hopeful about their progress so far.
“It’s really the only plant species I know of that makes these molecules,” added Kaminski.
This article originally appeared on Benzinga and has been republished with permission.
Post a comment: